HARMONY BIOSCIENCES HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
HARMONY BIOSCIENCES HOLDINGS, INC. (HRMY) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.66 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-04
- HARMONY BIOSCIENCES HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 621.90K shares, a 100.56% increase year-over-year.
- HARMONY BIOSCIENCES HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 1.04M shares, a 0.41% increase year-over-year.
- HARMONY BIOSCIENCES HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 28.85K shares.
- HARMONY BIOSCIENCES HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 51.10K shares, a 5.28% decline year-over-year.
- HARMONY BIOSCIENCES HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 1.43M shares, a 9.08% increase from fiscal 2024.
- HARMONY BIOSCIENCES HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 1.31M shares, a 197.31% increase from fiscal 2023.
- HARMONY BIOSCIENCES HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 440.29K shares, a 74.40% decline from fiscal 2022.
- HARMONY BIOSCIENCES HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 1.72M shares, a 10.83% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 621.90K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | 1.66M shares 10-Q · filed 2026-08-04 | 1.69M shares derived: sum of 3 quarters · filed 2026-08-04 | 1.74M shares derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | 1.04M shares 10-Q · filed 2026-05-07 | 1.07M shares derived: sum of 2 quarters · filed 2026-05-07 | 1.12M shares derived: sum of 3 quarters · filed 2026-05-07 | 1.43M shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 28.85K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 79.95K shares derived: sum of 2 quarters · filed 2026-02-24 | 390.03K shares derived: sum of 3 quarters · filed 2026-02-24 | 1.43M shares 10-K · filed 2026-02-24 |
| 2025-09-30 | 51.10K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | 361.18K shares derived: sum of 2 quarters · filed 2025-11-04 | 1.40M shares 10-Q · filed 2025-11-04 | 1.35M shares derived: sum of 4 quarters · filed 2025-11-04 |
| 2025-06-30 | 310.08K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | 1.35M shares 10-Q · filed 2025-08-05 | 1.30M shares derived: sum of 3 quarters · filed 2025-08-05 | 1.35M shares derived: sum of 4 quarters · filed 2025-08-05 |
| 2025-03-31 | 1.04M shares 10-Q · filed 2025-05-06 | 985.60K shares derived: sum of 2 quarters · filed 2025-05-06 | 1.04M shares derived: sum of 3 quarters · filed 2025-05-06 | 1.28M shares derived: sum of 4 quarters · filed 2025-05-06 |
| 2024-12-31 | -52.30K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | 1.65K shares derived: sum of 2 quarters · filed 2025-02-25 | 237.30K shares derived: sum of 3 quarters · filed 2025-02-25 | 1.31M shares 10-K · filed 2025-02-25 |
| 2024-09-30 | 53.95K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | 289.60K shares derived: sum of 2 quarters · filed 2024-10-29 | 1.36M shares 10-Q · filed 2024-10-29 | 1.43M shares derived: sum of 4 quarters · filed 2024-10-29 |
| 2024-06-30 | 235.65K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | 1.31M shares 10-Q · filed 2024-08-06 | 1.37M shares derived: sum of 3 quarters · filed 2024-08-06 | 1.44M shares derived: sum of 4 quarters · filed 2024-08-06 |
| 2024-03-31 | 1.07M shares 10-Q · filed 2024-04-30 | 1.14M shares derived: sum of 2 quarters · filed 2024-04-30 | 1.21M shares derived: sum of 3 quarters · filed 2024-04-30 | 1.41M shares derived: sum of 4 quarters · filed 2024-04-30 |
| 2023-12-31 | 63.87K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | 134.47K shares derived: sum of 2 quarters · filed 2024-02-22 | 340.50K shares derived: sum of 3 quarters · filed 2024-02-22 | 440.29K shares 10-K · filed 2024-02-22 |
| 2023-09-30 | 70.59K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | 276.63K shares derived: sum of 2 quarters · filed 2023-10-31 | 376.42K shares 10-Q · filed 2023-10-31 | 562.04K shares derived: sum of 4 quarters · filed 2023-10-31 |
| 2023-06-30 | 206.03K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | 305.83K shares 10-Q · filed 2023-08-01 | 491.45K shares derived: sum of 3 quarters · filed 2023-08-01 | 562.04K shares derived: sum of 4 quarters · filed 2023-08-01 |
| 2023-03-31 | 99.80K shares 10-Q · filed 2023-05-02 | 285.42K shares derived: sum of 2 quarters · filed 2023-05-02 | 356.01K shares derived: sum of 3 quarters · filed 2023-05-02 | 442.07K shares derived: sum of 4 quarters · filed 2023-05-02 |
| 2022-12-31 | 185.62K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | 256.21K shares derived: sum of 2 quarters · filed 2023-02-21 | 342.27K shares derived: sum of 3 quarters · filed 2023-02-21 | 1.72M shares 10-K · filed 2023-02-21 |
| 2022-09-30 | 70.59K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | 156.65K shares derived: sum of 2 quarters · filed 2022-11-01 | 1.53M shares 10-Q · filed 2022-11-01 | 1.69M shares derived: sum of 4 quarters · filed 2022-11-01 |
| 2022-06-30 | 86.06K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | 1.46M shares 10-Q · filed 2022-08-02 | 1.62M shares derived: sum of 3 quarters · filed 2022-08-02 | 1.72M shares derived: sum of 4 quarters · filed 2022-08-02 |
| 2022-03-31 | 1.38M shares 10-Q · filed 2022-05-03 | 1.54M shares derived: sum of 2 quarters · filed 2022-05-03 | 1.63M shares derived: sum of 3 quarters · filed 2022-05-03 | 1.82M shares derived: sum of 4 quarters · filed 2022-05-03 |
| 2021-12-31 | 159.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | 252.81K shares derived: sum of 2 quarters · filed 2022-02-28 | 438.90K shares derived: sum of 3 quarters · filed 2022-02-28 | 1.55M shares 10-K · filed 2022-02-28 |
| 2021-09-30 | 93.11K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | 279.20K shares derived: sum of 2 quarters · filed 2021-11-09 | 1.39M shares 10-Q · filed 2021-11-09 | 1.62M shares derived: sum of 4 quarters · filed 2021-11-09 |
| 2021-06-30 | 186.08K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | 1.30M shares 10-Q · filed 2021-08-10 | 1.52M shares derived: sum of 3 quarters · filed 2021-08-10 | |
| 2021-03-31 | 1.11M shares 10-Q · filed 2021-05-11 | 1.34M shares derived: sum of 2 quarters · filed 2021-05-11 | ||
| 2020-12-31 | 223.26K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | 3.04M shares 10-K · filed 2021-03-25 | ||
| 2020-09-30 | 2.81M shares 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |